Thielemans, K., Neyns, B., Wilgenhof, S., Corthals, J., & Heirman, C. (2014). Phase II study of autologous mRNA electroporated dendritic cells (TriMixDC-MEL) in combination with Ipilimumab in patients with pretreated advanced melanoma. J Immunother Cancer.
Citação norma ChicagoThielemans, Kris, Bart Neyns, Sofie Wilgenhof, Jurgen Corthals, and Carlo Heirman. "Phase II Study of Autologous MRNA Electroporated Dendritic Cells (TriMixDC-MEL) in Combination With Ipilimumab in Patients With Pretreated Advanced Melanoma." J Immunother Cancer 2014.
ציטוט MLAThielemans, Kris, et al. "Phase II Study of Autologous MRNA Electroporated Dendritic Cells (TriMixDC-MEL) in Combination With Ipilimumab in Patients With Pretreated Advanced Melanoma." J Immunother Cancer 2014.